Patents : |  |
| US Patent No. | Title |
| 7534772 | Methods for enhancing antibody-induced cell lysis and treating cancer
|
| 7557070 | Multiplexed cell analysis system
|
| 7560438 | Genetic inhibition by double-stranded RNA
|
| 7560531 | Cln101 antibody compositions and methods of use alone and in combination with prostate specific antigen and other cancer markers
|
| 7563447 | Yeast-based vaccines as immunotherapy
|
| 7563570 | Method of determining a chemotherapeutic regimen for non small cell lung cancer based on BRCA1 expression
|
| 7563572 | Method for long range allele-specific PCR
|
| 7563576 | Combinatorial decoding of random nucleic acid arrays
|
| 7563598 | Detection of truncation mutations by mass spectrometry
|
| 7563882 | Polynucleotides encoding antibodies that bind to the C35 polypeptide
|
| 7569577 | Quinazoline derivatives as tyrosine kinase inhibitors
|
| 7556944 | Methods and compositions for use in preparing siRNAs
|
| 7556920 | Gene BNO1 mapping to chromosome 16q24.3
|
| 7556796 | Directed complementation
|
| 7534785 | 3,6-dihydro-2-oxo-6H-1,3,4,-thiadiazine derivatives
|
| 7534918 | Histone deacetylase inhibitors
|
| 7537938 | Biomarker detection in circulating cells
|
| 7538095 | Genetic inhibition by double-stranded RNA
|
| 7541141 | Method of using estrogen-related receptor alpha (ERR.alpha.) status to determine prognosis, treatment strategy and predisposition to breast cancer, and method of using ERR.alpha. as a therapeutic target for the treatment of breast cancer
|
| 7544695 | Spirocyclic compounds
|
| 7547544 | Antibodies against GPR64 and uses thereof
|
| 7547687 | Therapeutic treatment methods
|
| 7550141 | Methods for imaging tumor vasculature using conjugates that bind to aminophospholipids
|
| 7553485 | Anti-IGF-IR and/or anti-insulin/IGF-I hybrid receptors antibodies and uses thereof
|
| 7572442 | Selected antibody compositions for binding to aminophospholipids
|
| 7572448 | Combined cancer treatment methods using selected antibodies to aminophospholipids
|
| 7598052 | Expression profile of thyroid cancer
|
| 7598060 | Rapid analysis of variations in a genome
|
| 7598383 | Heterocyclic inhibitors of MEK and methods of use thereof
|
| 7599933 | Coupled two-way clustering analysis of data
|
| 7601355 | Compositions and methods for altering immune function
|
| 7601505 | Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
|
| 7604995 | Compositions, kits, and methods for stimulation of homologous recombination
|
| 7608449 | Methods and compositions related to high-titer pseudotyped retroviruses
|
| 7611704 | Compositions and methods for treating viral infections using antibodies and immunoconjugates to aminophospholipids
|
| 7611839 | Methods for diagnosing RCC and other solid tumors
|
| 7592143 | Methods of treating diseases responsive to induction of apoptosis and screening assays
|
| 7589070 | Surface modification for improving biocompatibility
|
| 7589066 | Potent and specific immunoproteasome inhibitors
|
| 7576072 | Heterocyclic inhibitors of MEK and methods of use thereof
|
| 7576192 | Rapid and sensitive assay for the detection and quantification of coregulators of nucleic acid binding factors
|
| 7579349 | 4-(pyrazol-3-ylamino) pyrimidine derivatives for use in the treatment of cancer
|
| 7582606 | Nadph oxidase cytosolic cofactor mutant
|
| 7582644 | Pyrimidyl sulphone amide derivatives as chemokine receptor modulators
|
| 7585867 | Substituted thiazolo[4,5-d]pyrimidin-2(3H)-one
|
| 7587078 | Automated image analysis
|
| 7588767 | Microorganisms for therapy
|
| 7588771 | Microorganisms for therapy
|
| 7588904 | Perinucleolar compartment as a cancer marker
|
| 7612077 | Crystalline forms of the anti-cancer compound ZD1839
|
